EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout

Chanaka Dahanayake, Kelsey M. Jordan, Edward Roddy

Gout, Urate, and Crystal Deposition Disease · 2023

DOI: 10.3390/gucdd1010002 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Gout, Urate, and Crystal Deposition Disease, 2023. Verfasst von Chanaka Dahanayake und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gout is the most common inflammatory arthritis and causes significant pain and disability [...]

Zitieren

APA

Dahanayake, C., Jordan, K. M., & Roddy, E. (2023). Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout. Gout, Urate, and Crystal Deposition Disease. https://doi.org/10.3390/gucdd1010002

Vancouver

Dahanayake C, Jordan KM, Roddy E. Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout. Gout, Urate, and Crystal Deposition Disease. 2023. doi:10.3390/gucdd1010002

BibTeX
@article{Dahanayake2023,
  author = {Dahanayake, Chanaka and Jordan, Kelsey M. and Roddy, Edward},
  title = {Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout},
  journal = {Gout, Urate, and Crystal Deposition Disease},
  year = {2023},
  doi = {10.3390/gucdd1010002}
}
Kostenlos starten →